Press Releases
April 12, 2024
U.S. FDA Completes Inspection of Lupin’s Dabhasa Facility with No Observations
April 9, 2024
Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules) in the United States
April 8, 2024
Lupin Receives Approval from U.S. FDA for Valbenazine Capsules
April 1, 2024
Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules
March 28, 2024
Lupin Receives Approval from U.S. FDA for Eslicarbazepine Acetate Tablets
March 19, 2024
Lupin Receives Approval from U.S. FDA for Aripiprazole Tablets, USP
March 15, 2024
Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP
February 16, 2024
Lupin Receives Approval from U.S. FDA for Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets)
February 15, 2024
Lupin Launches Ganirelix Acetate Injection in the United States
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comSmart Guide
Close

Search Product
